Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Optimized tumor cryptic peptides: the basis for universal neo-antigen-like tumor vaccines

1 Jul 2016

Abstract excerpt

The very impressive clinical results recently obtained in cancer patients treated with immune response checkpoint inhibitors boosted the interest in immunotherapy as a therapeutic choice in cancer treatment. However, these inhibitors require a pre-existing tumor specific immune response and the presence of tumor infiltrating T cells to be efficient. This immune response can be triggered by cancer vaccines. One of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Immunotherapy and Immune Responses
Share to vaccines and immunoinformatics approaches

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27563653
DOI: 10.21037/atm.2016.05.15

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Optimized tumor cryptic peptides: the basis for universal neo-antigen-like tumor vaccinesPMID 27563653Read ↗

Cryptic but critical: non-canonical antigens in cancer immunotherapy.Semantic proximity Read ↗

Cancer Vaccines: Recent Insights and Future DirectionsSemantic proximity Read ↗

Tumor Antigens beyond the Human Exome.Semantic proximity Read ↗

Personalized neoantigen vaccination with synthetic long peptides: recent advances and future perspectives.Semantic proximity Read ↗

Structural and physical features that distinguish tumor-controlling from inactive cancer neoepitopesSemantic proximity Read ↗

An unbiased approach to defining bona fide cancer neoepitopes that elicit immune-mediated cancer rejectionSemantic proximity Read ↗

Mutanome directed cancer immunotherapy.Semantic proximity Read ↗

Sequential administration of the native TERT572 cryptic peptide enhances the immune response initiated by its optimized variant TERT(572Y) in cancer patients.Semantic proximity Read ↗

The double-edged sword of cancer mutations: exploiting neoepitopes for the fight against cancer.Semantic proximity Read ↗

Discovery and Subtyping of Neo-Epitope Specific T-Cell Responses for Cancer Immunotherapy: Addressing the Mutanome.Semantic proximity Read ↗

Can we predict mutant neoepitopes in human cancers for patient-specific vaccine therapy?Semantic proximity Read ↗

Natural and cryptic peptides dominate the immunopeptidome of atypical teratoid rhabdoid tumorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.